Geftib Tablet

Introduction to Geftib Tablet

The Geftib Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain gene mutations called EGFR mutations. This tablet is often prescribed to patients who have not undergone prior chemotherapy.

Composition of Geftib Tablet

The active ingredient in Geftib Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting the mutated EGFR receptors.

Uses of Geftib Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Effective for patients with specific EGFR gene mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Geftib Tablet

Common Side Effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious Side Effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Geftib Tablet

Geftib Tablet should not be taken by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Geftib Tablet

• Take one 250 mg tablet orally once daily.
• Consume the tablet at the same time each day for consistency.
• Follow your healthcare provider's instructions carefully.

Conclusion of Geftib Tablet

The Geftib Tablet is a targeted therapy for treating non-small cell lung cancer with specific EGFR mutations. While it offers significant benefits, it is essential to be aware of its side effects and take necessary precautions. Always consult with your healthcare provider to ensure it is the right treatment for you.